Author:
Ho A.D.,Suciu S.,Stryckmans P.,De Cataldo F.,Willemze R.,Thaler J.,Peetermans M.,Döhner H.,Solbu G.,Dardenne M.,Zittoun R.
Reference50 articles.
1. A novel adenosine and araA deaminase inhibitor, (R)-3-(2-deoxy-P-D-erythro-pentofurano-syl)-3,6,7,8-tetra-hydroamidazo (4,5-d) (1,3) diazepin-8-ol;Woo;J Heterocyclic Chem,1974
2. Adenosine deaminase deficiency in two patients with severely impaired cellular immunity;Giblett;Lancet,1972
3. The clinical pharmacology of the adenosine deaminase inhibitor 2’-deoxycoformycin;Smyth;Cancer Chemother Pharmacol,1980
4. The biochemical and clinical consequences of 2’-deoxycoformycin in refractory lymphoproliferative malignancy;Grever;Blood,1981
5. Trimmer KB et al;Mills;Purine metabolism in adenosine deaminase deficiency. Proc Natl Acad Sci USA,1976
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献